FindTrial
Sign In

Studying the evolution and expression of anxiety in silicea medicine

Studying the evolution and expression of anxiety in Silicea through clinical cases -Observational Retrospective case series - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084242
Enrollment
30
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L943- Sclerodactyly

Interventions

Intervention1: NIL: NIL

Sponsors

Dr M L Dhawale Memorial Homoeopathic Institute, Palghar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the cases where the medicine has shown adequate remedy registration with minimum 3 months follow up Not more than 5 cases from pediatric age group. Cases from both sexes.

Exclusion criteria

Exclusion criteria: cases lacking in information about evolution and expression of anxiety

Design outcomes

Primary

MeasureTime frame
To study the evolution and expression of anxiety of Silicea.Timepoint: 1.5 years—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDr Sneha Anil Bhavekar

Dr M L Dhawale Memorial Homoeopathic Institute, Palghar

vivekkadam84@gmail.com7720016351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026